# Trade Mark Journal No.2025/050 12 December 2025

## WO0000001888618 (5)

Office of origin: Republic of Korea

Date of International Registration:16 October 2025
Date of designation in the UK: 16 October 2025

International priority date claimed: 18 April 2025 (Republic of Korea) (4020250066000)

Class 5
  Monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; immunomodulatory pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune diseases.

CELLTRION, INC.

Representative: JIDAM IP LAW FIRM, A-201, U Space 2, 670, Deawangpangyo-ro,, Bundang-gu, Seongnam-si, Gyeonggi-do, REPUBLIC OF KOREA